In order to better understand the regulation of EVI1 in 3q-rearranged AML, we have performed proteomic analyses of chromatin-bound TFs known to be present at G2DHE, such as CEBPA and RUNX1, and have identified colocalizing complex members of the super-enhancer. The gene discussed is MECOM; the disease is acute myeloid leukemia.